Back

Corrigendum to: PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1

Cardiovascular Research

14 December 2021
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes
28 August 2023
thumbnail
Congress Presentation
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
31 August 2025
thumbnail
Congress Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
2 September 2019
thumbnail
Congress Presentation
Effect of PCSK9 inhibitors on coronary plaque: a meta-analysis and trial sequential analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources